Patient-level. (A) Flow chart indicating overall patient LRP study cohort with evaluable follow-up up to 24 months. Plaque-level. (B) Flow Chart reporting overall LRP study cohort with evaluable follow-up up to 24 months. DM, diabetes mellitus (includes ITDM + non-ITDM); ITDM, insulin-treated diabetic patients; NC-MACE, non-culprit major adverse cardiac events; noDM, non-diabetic patients; non-ITDM, non-insulin-treated diabetic patients.